By: yuka.osada On: August 6, 2025 FDA Inspection Observations & Form 483: Practical Insights for Industry, Clinical & Regulatory Professionals
By: yuka.osada On: June 18, 2025 Global Clinical Trial Disclosure in the U.S. – What Every Clinical Team Needs to Know
By: yuka.osada On: May 28, 2025 Fast-Tracking Cures for Rare Diseases: Inside the FDA’s START Pilot Program
By: yuka.osada On: May 21, 2025 Psychedelic Medicine on the Rise: How Regulators Are Shaping Mental Health Treatment
By: yuka.osada On: April 23, 2025 FDA’s QIDP Designation: The Game-Changer in Antimicrobial Drug Innovation
By: yuka.osada On: April 16, 2025 RMAT-The Regulatory Catalyst for Accelerating Regenerative Medicine Therapies
